Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people do feel colder than usual while taking Wegovy, and there is a plausible explanation: when your body is losing fat relatively quickly, it produces less metabolic heat. Feeling cold on Wegovy is not an official listed side effect in the semaglutide SmPC, but it is a pattern reported by real patients and discussed in clinical practice. It tends to be mild and temporary. As with any symptom that concerns you, a quick word with your prescriber is the right first step — these are prescription-only medicines, and clinical support is part of the package. Learn more about how Wegovy works, or read on for what the evidence and clinical experience actually suggest.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Fat tissue is not passive storage. It insulates the body and contributes to resting thermogenesis, the background heat your metabolism generates just by existing. Lose a meaningful amount of it in a relatively short window, and both of those functions diminish. Patients who lose weight quickly on any effective treatment sometimes find they need an extra layer in rooms that never bothered them before.
There is a second thread worth understanding. Semaglutide, the active ingredient in Wegovy, significantly reduces appetite. How Wegovy affects appetite and energy levels is a question our prescribers hear most weeks. When you eat substantially less, your body generates less dietary thermogenesis, the warmth produced during digestion and metabolism of food. The combined effect of reduced calorie intake and shrinking fat reserves can leave some people genuinely colder, especially in cooler rooms or at night.
A practical check worth doing: note whether the cold feeling is worst in the first day or two after your weekly injection. Some patients report a mild flu-like sense of feeling off (including feeling cold) in the window shortly after dosing. That pattern, if it fits yours, is more likely tied to the injection cycle than to weight loss itself.
The NHS semaglutide medicines page lists the recognised common side effects of Wegovy, and cold sensation does not appear among them. That does not mean the experience is not real; it means it has not reached the frequency threshold for formal listing in the approved product information.
For most people who notice it, the feeling is intermittent rather than constant. It is often most noticeable in the early months of treatment, when weight is coming off most rapidly. As the rate of loss slows and the body adjusts to its new baseline, the cold sensitivity frequently diminishes too.
A smaller number of patients find it persists. Persistent cold feelings throughout treatment are worth investigating rather than simply tolerating. The key question is whether something else is running alongside the weight loss. Hypothyroidism (an underactive thyroid) produces cold intolerance as one of its hallmark symptoms, and it is entirely possible for someone to start a weight-loss medicine around the same time an unrelated thyroid condition develops or becomes noticeable. Fatigue, dry skin, hair thinning, and low mood alongside cold intolerance are the signal to ask your GP for a thyroid function test.
Anaemia is another possibility: semaglutide does not cause anaemia directly, but reduced dietary intake can occasionally affect iron or B12 levels if protein and micronutrient intake is not maintained. Low iron is a well-established cause of feeling cold. If you are concerned about either possibility, that is a conversation for your prescriber or GP rather than something to self-manage.
Start by ruling out the straightforward. Are you eating enough protein and sufficient calories to support daily function? Undereating beyond what is clinically appropriate can compound the thermogenesis effect. A dietitian's input is genuinely useful here, a reduced-calorie diet structured around protein and micronutrients is quite different from an unplanned steep restriction.
Check whether the cold sensation tracks with your injection schedule. If it eases by day four or five and returns after the next dose, that pattern is meaningful clinical information to share with your prescriber. Whether semaglutide specifically drives cold sensitivity is something the clinical team can explore with you in the context of your full history.
If you are taking Wegovy through a private service, aftercare access matters here. At nume, prescribers are available seven days a week for exactly this kind of question. Cold intolerance that is new, worsening, or accompanied by other symptoms should prompt a proper clinical review, not just reassurance from a forum. You can also report any unexpected symptom via the MHRA Yellow Card scheme, which helps the regulator track real-world experience with newer medicines.
For a broader picture of what Wegovy patients typically experience, the fuller account of cold sensations reported by Wegovy users covers more of the detail. And if you are weighing up what treatment through a private clinic actually involves, the cost context for private Wegovy in the UK is a reasonable place to understand what a complete service should include.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.